
Background:Chronic subdural hematoma (CSDH) is increasingly common in older adults. Although burr-hole evacuation is effective, outcome and recurrence remain variable. This study evaluated the predictors of outcome and recurrence after a uniform double burr-hole technique. Materials and Methods:In this prospective observational study, 101 symptomatic CSDH patients admitted to Dayanand Medical College and Hospital, Ludhiana (July 2023-September 2024) underwent double burr-hole craniostomy with subdural drain. Demographic variables, comorbidities, antithrombotic use, alcohol intake, clinical status (Glasgow Coma Scale [GCS], Markwalder grade, and modified Rankin scale mRS), CT findings (density, thickness, midline shift, laterality, membranes, and cerebral atrophy), laboratory parameters (international normalized ratio [INR], serum albumin, and total proteins), intraoperative findings, complications, recurrence, and hospital stay were recorded. Outcomes were assessed using the Glasgow Outcome Scale (GOS) at discharge and at 2 months and dichotomized as favorable (GOS 5) or unfavorable (GOS 1-4). Results:The cohort was predominantly male (81.2%) and elderly. Favorable outcome was achieved in 78.2% at discharge and 84.2% at 2 months; recurrence occurred in 14.9%. Unfavorable discharge outcome was significantly associated with older age (P = 0.027), hypertension (P = 0.026), poorer neurological status (higher Markwalder grade, higher mRS, lower GCS; all P < 0.001), bilateral hematoma (P = 0.037), cerebral atrophy (P = 0.021), intraoperative membranes (P = 0.036), higher INR (P = 0.047), and lower serum albumin (P < 0.001) and total proteins (P = 0.002). Hematoma thickness and midline shift were not predictive. Recurrence was significantly associated with hypertension (P = 0.046), blood thinner use (P = 0.001), alcohol consumption (P < 0.001), and higher INR (P = 0.007). Recurrence strongly predicted unfavorable follow-up outcome (P < 0.001). Conclusion:After uniform double burr-hole evacuation, outcome and recurrence in CSDH are primarily influenced by baseline neurological status, vascular comorbidity, cerebral atrophy, membrane formation, and coagulation/nutritional markers, with antithrombotics and alcohol strongly increasing recurrence risk.
Background:Staphylococcus aureus is a major pathogenic organism responsible for various infections. The emergence of methicillin-resistant S. aureus (MRSA) and inducible clindamycin resistance (ICR) complicates treatment and highlights the importance of accurate detection of Macrolide-Lincosamide-Streptogramin B (MLSB) resistance mechanisms. Aims/Objectives:This study aimed to assess the antimicrobial susceptibility pattern of S. aureus, detect ICR using the D-zone test, and evaluate its association with MRSA. Methodology:A total of 212 nonduplicate S. aureus isolates were obtained from various clinical samples at Medical College Baroda. Identification was performed using standard microbiological techniques. Antimicrobial susceptibility was tested using the Kirby-Bauer disk diffusion method and interpreted as per the Clinical and Laboratory Standards Institute guidelines. MRSA was identified using cefoxitin (30 µg), and ICR was detected via the D-zone test. Results:Among 212 isolates, 124 (58.49%) were male and 88 (41.51%) were female. MRSA was detected in 40 (18.87%) isolates. ICR (inducible MLSB [iMLSB]) was seen in 48 (22.64%) isolates, MS phenotype in 21 (9.90%) and constitutive MLSB in 9 (4.24%). A significant association was found between MRSA and iMLSB (P < 0.05). Conclusion:Routine D-zone testing is essential to detect inducible resistance. Continued surveillance and rational antibiotic use are necessary to prevent resistance spread.
Background: Cancer patients are at increased risk of coronary artery disease. Vascular dysfunction is first reflected as arterial stiffness, which can be assessed by pulse wave velocity (PWV). Aim: This study aims to appraise whether PWV is a clinical indicator of arterial stiffness. Materials and Methods: A case-control observational study was undertaken in a tertiary teaching hospital among 589 participants, including 197 cancer patients undergoing treatment and 392 age-matched controls. Arterial stiffness and hemodynamic parameters were measured noninvasively using the Diabetes Risk Profiler system based on PeriScope ® technology. Statistical analysis included comparison of means, correlation analysis, and multiple linear regression. Results: Cancer patients showed significantly higher heart rate, systolic and diastolic blood pressure, pulse pressure, brachial-ankle PWV, carotid-femoral PWV, aortic pulse pressure, augmentation pressure, and augmentation index than controls, while ankle-brachial index was significantly lower (all P < 0.001). In cancer patients, PWV showed strong positive correlations with age and systolic blood pressure. Conclusion: Cancer patients undergoing treatment have markedly increased arterial stiffness and altered vascular function compared with controls. PWV may be a useful, simple, and noninvasive marker for early cardiovascular risk assessment in cardio-oncology practice.
Background:Left bundle branch pacing (LBBP) is developing as an effective technique for cardiac pacing, offering potential advantages over traditional right ventricular pacing methods. However, comprehensive assessment of LBBP outcomes across various indications and over extended follow-up periods is limited. This single-center prospective study aims to address this gap by evaluating the electrophysiological, echocardiographic, and clinical outcomes of LBBP over a 12-month follow-up period. Methods:This was a single-center prospective cohort study with repeated follow-up assessments performed at 3, 6, and 12 months following left bundle branch area pacing (LBBAP) implantation. This study enrolled 63 patients aged 18-80 with symptomatic bradyarrhythmia and left ventricular dysfunction undergoing LBBAP using Select Secure pacing leads. Outcomes were compared pre- and post-implantation at 3-, 6-, and 12-month follow-up, assessing electrophysiological parameters, cardiac function, and adverse events. Results:In this study, successful implantation was achieved in all patients, with selective LBB capture demonstrated in 78.9%. Lead parameters such as capture threshold, paced QRS duration, pacing impedance, and R wave amplitude at 3, 6, and 12 months when compared with the baseline, remained stable with no significant changes over time. Individuals with lower baseline ejection fraction EF improved significantly from baseline between 3 and 6 months, 6 and 12 months, and 3 and 12 months, respectively. Procedural and late complications were minimal. Conclusion:With improvements observed in electrophysiological parameters, cardiac function, and minimal adverse events over a 12-month follow-up period, LBBP demonstrates both efficacy and safety in this patient population. These results advocate for further exploration and utilization of LBBP as a preferred pacing strategy in clinical practice.